NCT00503295: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung |
|
|
| Completed | 2 | 53 | US | REOLYSIN® | Oncolytics Biotech | Osteosarcoma, Ewing Sarcoma Family Tumors, Malignant Fibrous Histiocytoma, Sarcoma, Synovial, Fibrosarcoma, Leiomyosarcoma | 02/11 | 04/11 | | |
